The combination of mild photothermal therapy and anti‐PD‐L1 peptide delivery effectively suppressed primary tumor growth and stimulated systemic anti‐tumor immunity (Figure 7B; Figure S10A–C, Supporting Information). This evidence concerns the gene CD274 and neoplasm.